{"id":"W2128628205","doi":"10.1016/s1470-2045(13)70479-0","title":"Docetaxel and dasatinib or placebo in men with metastatic castration-resistant prostate cancer (READY): a randomised, double-blind phase 3 trial","year":2013,"lang":"en","type":"article","venue":"The Lancet Oncology","topic":"Bone health and treatments","field":"Medicine","cited_by":231,"is_retracted":false,"has_abstract":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal; Bristol-Myers Squibb (Canada)","funders":"National Cancer Institute","keywords":"Medicine; Dasatinib; Docetaxel; Prostate cancer; Internal medicine; Oncology; Clinical endpoint; Placebo; Chemotherapy; Cancer; Urology; Clinical trial; Tyrosine kinase; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005739131,0.0001733197,0.0007670064,0.00006512502,0.0000873222,0.00002256638,0.0000608064,0.00006195327,0.0002941778],"category_scores_gemma":[0.00004802216,0.00008268281,0.00002223481,0.0001531215,0.0001408263,0.00008415496,0.00001602236,0.0002332478,0.00002347451],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001405768,"about_ca_system_score_gemma":0.0008462758,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.004274504,"about_ca_topic_score_gemma":0.00736251,"domain_scores_codex":[0.9985805,0.0002272407,0.0003910963,0.0002403501,0.0001555367,0.0004053033],"domain_scores_gemma":[0.9989488,0.0003982435,0.0001953488,0.0002254355,0.00006715487,0.0001650207],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9873059,0.0006337442,0.0007449095,0.0001128074,0.0002081136,0.0001893216,0.001379666,0.000005242481,0.0002409348,0.00008861641,0.001665393,0.007425299],"study_design_scores_gemma":[0.9881122,0.00500848,0.001930376,0.00006299392,0.0003230996,0.000128787,0.0003543932,0.0002178533,0.0001035517,0.0000940707,0.003564613,0.00009956994],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9750188,0.0003955966,0.000003849188,0.01199431,0.00007293758,0.008157258,0.00003273284,0.00002498324,0.004299503],"genre_scores_gemma":[0.989922,0.0004365796,0.0008317502,0.001151707,0.0001734752,0.005030517,0.00004801122,0.00002115026,0.002384826],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01490316,"threshold_uncertainty_score":0.64618,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1322022653686313,"score_gpt":0.4325167925736302,"score_spread":0.3003145272049989,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}